|
|
 |
|
Viewing report
|
|
|
|
Edwards Lifesciences Medical Device Company Intelligence Report
Espicom Business Intelligence Ltd, March 2012, Pages: 36
Edwards Lifesciences is a global provider of products and technologies that are designed to treat advanced cardiovascular disease. The company is focused specifically on technologies that treat structural heart disease and critically ill patients.
The products and technologies offered by Edwards to treat advanced cardiovascular disease are categorised into four main areas: Heart Valve Therapy, Critical Care, Cardiac Surgery Systems and Vascular.
Heart Valve Therapy - Edwards claims to be the leading manufacturer of tissue heart valves and repair products, which are used to replace or repair a patient’s diseased or defective heart valve. The company produces pericardial and porcine valves from biologically-inert animal tissue sewn onto proprietary wire form stents.
Critical Care – Edwards’ range of Critical Care products include haemodynamic monitoring equipment that is used to measure a patient's cardiovascular function, disposable pressure transducers and central venous access products for fluid and drug delivery. In September 2009, Edwards sold certain assets related to its haemofiltration product range to Baxter International.
Cardiac Surgery Systems – Edwards’ Cardiac Surgery Systems products include a range of products for use during cardiac surgery, including cannulae, the Embol-X intra-aortic filtration system and certain other disposable products used during cardiopulmonary bypass procedures.
Vascular – Edwards manufactures a variety of products used to treat vascular disease, including balloon-tipped, catheter-based embolectomy products, surgical clips and clamps.
Edwards’ global brands include Carpentier-Edwards, Cosgrove-Edwards, Edwards Sapien, FloTrac, Fogarty, Perimount Magna and Swan-Ganz. The company’s products are sold in approximately 100 countries.
Edwards is based in Irvine, California, US, and employs approximately 7,800 people worldwide. The company’s regional headquarters are located in St Prex, Switzerland; and Tokyo, Japan. In the year ended 31st December 2011, the company generated sales of US$1,679 million.
KEY TOPICS COVERED
This company report provides:
Overview
Key contact information
Introduction to the company and its current activities
Summary of its financial performance
Who are the company’s major competitors?
Key recent events in an “at a glance” format
Financial Review
Current year and annual financial data, including revenue breakdowns by product area and geographic region (if available)
Table providing in-depth five-year financial analysis
Employee data, including breakdown by company division and geographic location
Strategic Focus
Investigates the company’s aims and its areas of focus
Products
Core product areas, key brands, product approvals and launches Research and Development
How much has been invested in R&D?
Where is the research based?
What alliances and agreements does the company have and with whom?
Manufacturing and Distribution
Identifying the company’s manufacturing locations
Sales and marketing facilities
Agreements
With whom has the company reached agreements and what do they involve?
Key contracts awarded
Mergers, Acquisitions, Minority Investments and Divestments
Litigation
Key Corporate Events
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Cardiac Prosthetic Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Medical Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Global Cardiovascular Surgery Devices Market Trends and Future Forecast (2009 - 2014)
Cardiac Defibrillators - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Pacemakers - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Cardiac Catheters - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Embolic Protection Devices (EPD) - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Electrophysiology (EP) Laboratory Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Electrocardiography (ECG) Devices - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
Coronary Stents - Emerging Markets (Brazil, Russia, India, China, South Africa And South Korea), 2009-2015
|
|
|
|
